2025 · 2nd Quarter (Apr 1 - June 30)

ELEVANCE HEALTH, INC.

Filed by MEHLMAN CONSULTING, INC..

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 21, 2025
Income: $90,000.00
Expenses: Not reported
Registrant: MEHLMAN CONSULTING, INC.
Client: ELEVANCE HEALTH, INC.
Filing UUID: 74b35d57-aeee-48e1-a362-007bb5e92f32
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to health insurance price transparency. Issues related to prescription drug costs and delivery. H.R. 1 - One Big Beautiful Bill Act.

Literal federal measure citations: H.R. 1

MMM · Medicare/Medicaid

Medicare Advantage, Medicare Part D, Medicaid Managed Care. Issues related to prescription drug costs and delivery. Medicare Advantage rate notice. PBM Reform issues. S. 1105 - No UPCODE Act. H.R. 1 - One Big Beautiful Bill Act.

Literal federal measure citations: S. 1105, H.R. 1

PHA · Pharmacy

Prescription Drug Pricing.

TAX · Taxation/Internal Revenue Code

Issues related to advanced premium tax credits. H.R. 1 - One Big Beautiful Bill Act.

Literal federal measure citations: H.R. 1

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.